Farallon Capital Management 13F holdings, Q4 2017
Holdings as of December 31, 2017 · filings on SEC EDGAR · latest filing →
Farallon Capital Management disclosed 79 US equity positions worth $10.0bn in its Q4 2017 13F filing. The largest position was AETNA INC NEW at 9.4% of the reported book, followed by NXPI and ALTABA INC. Against the Q3 2017 filing, it opened 4 new positions, added to 29 and reduced 12 among the top 50 holdings.
What did Farallon Capital Management own in Q4 2017? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2017 |
|---|---|---|---|---|---|---|---|
| 1 | AETNA INC NEW | 9.4% | $940.7m | 5,215,000 | – | new | |
| 2 | NXPI NXP SEMICONDUCTORS N V | Technology | 9.2% | $915.1m | 7,815,000 | 1% | added |
| 3 | ALTABA INC | 8.2% | $821.3m | 11,757,457 | -3% | reduced | |
| 4 | WAB WABTEC CORP | Industrials | 4.4% | $440.5m | 5,409,481 | 22% | added |
| 5 | TIME WARNER INC | 3.9% | $390.1m | 4,265,000 | -49% | reduced | |
| 6 | DELL DELL TECHNOLOGIES INC | Technology | 3.8% | $382.3m | 4,703,440 | 4% | added |
| 7 | ROCKWELL COLLINS INC | 3.4% | $342.9m | 2,528,044 | – | new | |
| 8 | PLAYA HOTELS & RESORTS NV | 3.3% | $330.2m | 30,606,930 | 0% | held | |
| 9 | V VISA INC | Financial Services | 3.1% | $304.7m | 2,671,998 | 13% | added |
| 10 | IQV IQVIA HLDGS INC | Healthcare | 2.9% | $290.1m | 2,962,944 | – | new |
| 11 | GOOG ALPHABET INC | Communication Services | 2.7% | $273.9m | 261,713 | -33% | reduced |
| 12 | META FACEBOOK INC | Communication Services | 2.7% | $269.3m | 1,525,903 | -18% | reduced |
| 13 | TRU TRANSUNION | Financial Services | 2.1% | $206.3m | 3,754,262 | 62% | added |
| 14 | MSFT MICROSOFT CORP | Technology | 2.0% | $197.2m | 2,305,634 | -11% | reduced |
| 15 | CITRIX SYS INC | 2.0% | $195.4m | 2,220,383 | -24% | reduced | |
| 16 | FIS FIDELITY NATL INFORMATION SV | Technology | 1.9% | $191.1m | 2,031,376 | 29% | added |
| 17 | IHS MARKIT LTD | 1.9% | $190.4m | 4,217,914 | 33% | added | |
| 18 | ELV ANTHEM INC | Healthcare | 1.9% | $185.2m | 823,000 | 292% | added |
| 19 | BIIB BIOGEN INC | Healthcare | 1.7% | $172.0m | 540,000 | 14% | added |
| 20 | MONSANTO CO NEW | 1.7% | $168.7m | 1,445,000 | 1506% | added | |
| 21 | BUD ANHEUSER BUSCH INBEV SA/NV | Consumer Defensive | 1.6% | $164.0m | 1,470,192 | 63% | added |
| 22 | CALPINE CORP | 1.6% | $163.4m | 10,801,403 | 67% | added | |
| 23 | VRSK VERISK ANALYTICS INC | Industrials | 1.6% | $159.7m | 1,663,403 | 2% | added |
| 24 | CHTR CHARTER COMMUNICATIONS INC N | Communication Services | 1.6% | $155.8m | 463,625 | 142% | added |
| 25 | EFX EQUIFAX INC | Industrials | 1.5% | $153.2m | 1,299,175 | 1% | added |
| 26 | LIBERTY GLOBAL PLC | 1.4% | $138.8m | 4,102,123 | 33% | added | |
| 27 | AZN ASTRAZENECA PLC | Healthcare | 1.3% | $130.6m | 3,765,000 | 18% | added |
| 28 | RADIUS HEALTH INC | 1.3% | $125.1m | 3,936,300 | 0% | held | |
| 29 | LIBERTY GLOBAL PLC | 1.2% | $117.2m | 3,270,180 | 9% | added | |
| 30 | VEON VEON LTD | 1.1% | $113.0m | 29,433,518 | 0% | held | |
| 31 | HUN HUNTSMAN CORP | Basic Materials | 0.8% | $80.7m | 2,425,000 | -31% | reduced |
| 32 | FIBROGEN INC | 0.8% | $78.6m | 1,657,500 | 51% | added | |
| 33 | BMY BRISTOL MYERS SQUIBB CO | Healthcare | 0.7% | $73.1m | 1,192,500 | -12% | reduced |
| 34 | AKORN INC | 0.7% | $72.6m | 2,251,300 | -1% | reduced | |
| 35 | ABBV ABBVIE INC | Healthcare | 0.7% | $67.7m | 700,000 | 20% | added |
| 36 | SG7 SAGE THERAPEUTICS INC | 0.7% | $65.9m | 400,000 | 64% | added | |
| 37 | GENERAL COMMUNICATION INC | 0.6% | $64.1m | 1,643,800 | 0% | held | |
| 38 | ABLYNX NV | 0.6% | $58.7m | 2,350,000 | – | new | |
| 39 | ANAB ANAPTYSBIO INC | Healthcare | 0.6% | $56.5m | 561,000 | 128% | added |
| 40 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.5% | $54.3m | 925,000 | 124% | added |
| 41 | QCOM QUALCOMM INC | Technology | 0.5% | $50.6m | 789,783 | 829% | added |
| 42 | XLRN ACCELERON PHARMA INC | 0.5% | $46.2m | 1,088,000 | 13% | added | |
| 43 | AM6 AMICUS THERAPEUTICS INC | 0.4% | $40.0m | 2,781,000 | -45% | reduced | |
| 44 | MYOKARDIA INC | 0.4% | $36.4m | 863,732 | 117% | added | |
| 45 | ZOGENIX INC | 0.3% | $34.0m | 850,000 | 166% | added | |
| 46 | SUTHERLAND ASSET MGMT CORP M | 0.3% | $33.3m | 2,200,007 | -5% | reduced | |
| 47 | SVRA SAVARA INC | Healthcare | 0.3% | $33.0m | 2,225,000 | 0% | held |
| 48 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 0.3% | $32.4m | 645,000 | 43% | added |
| 49 | GRFS GRIFOLS S A | Healthcare | 0.3% | $32.3m | 1,408,760 | -1% | reduced |
| 50 | LKFT GALAPAGOS NV | Healthcare | 0.3% | $27.2m | 290,000 | 23% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.